FDA: Food Safety Tips for Healthy Holidays
December 3, 2008
WASHINGTON(RushPRnews)12/03/08-Parties, family dinners, and other gatherings where food is served are all part of the holiday cheer. But the merriment can change to misery if food makes you or others ill.Typical symptoms of foodborne illness are stomach pain, vomiting, and diarrhea, which often start a few days after consuming contaminated food or drink.
Read more
VOA Marks World AIDS Day With Special Programs
December 3, 2008
Washington, D.C., (RushPRnews)12/03/08- - The Voice of America (VOA) marked World AIDS Day with programming on the prevention and treatment of the disease with special attention focused on Africa, home to two-thirds of all people living with HIV.
Read more
Melamine in U.S. Baby Formula Questions and Answers About Trace Amounts of Melamine in U.S. Infant Formula
December 1, 2008
By Daniel J. DeNoon WebMD Health News Reviewed by Louise Chang, MD
WASHINGTON(RushPRnews)12/01/08-Tiny “trace” amounts of potentially toxic melamine reportedly detected in U.S.-made infant formula pose little if any risk to kids, experts tell WebMD. Investigative reporters for the Associated Press obtained FDA documents showing the agency has been testing U.S. made baby formula for melamine.
Read more
FDA Warns Public of Holidays Extortion Scam by FDA Impersonators
November 28, 2008
WASHINGTON(RushPRnews)11/28/08-The U.S. Food and Drug Administration is warning consumers about a fraudulent scheme to extort money from consumers by callers who falsely identify themselves as “FDA special agents” or other FDA officials. Several instances have been reported to the FDA of calls enticing consumers to purchase discounted prescription drugs by wiring funds to one of several locations in the Dominican Republic. No medications are ever delivered. A subsequent call is received from a fraudulent “FDA special agent” informing the consumer that a fine of several thousand dollars is required to be sent to an address in the Dominican Republic to prevent incarceration or other legal action.
Read more
FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer
November 11, 2008
CINCINNATI(RushPRnews)11/11/08–As part of the U.S. Food and Drug Administration’s ongoing efforts to ensure that heparin for patients remains safe, the government today seized 11 lots of heparin from Celsus Laboratories Inc. in Cincinnati, Ohio.
The five lots of Heparin Sodium Active Pharmaceutical Ingredient (API) and six lots of Heparin Lithium were seized at the FDA’s request by U.S. Marshals. These products, which were manufactured from material imported from China, had been found by the agency to be contaminated with over-sulfated chondroitin sulfate (OSCS), a substance that mimics heparin’s anticoagulant activity. Read more
Obama Wins: What It Means for Health Care
November 5, 2008
Experts Say Financial Crisis Could Affect Obama’s Plans for Health Care Reform
By Salynn Boyles
WASHINGTON,DC(RushPRnews)11/05/08– Tuesday’s election of Democrat Barack Obama ushers in a new administration that is all but certain to include some level of health care reform. Less clear is how extensive that reform will be and when it will come.
Read more
FDA: West Virginia Livestock Owner Sentenced in Criminal and Civil Contempt Case
September 11, 2008
WEST VIRGINIA,(RUSHPRNEWS)09/11/2008–The U.S. Food and Drug Administration announced today that a West Virginia cattle dealer has been sentenced to six months probation for refusing to obey court orders in 2006 and 2008 that prohibited her from introducing animals into the food supply until the FDA had approved her record-keeping system. The FDA initiated the case after illegal levels of drug residue were found repeatedly in calves that Shirley A. Rhodes of Sandyville sold for use as human food.
Read more
FDA to Post Quarterly Report of Potential Safety Issues
September 8, 2008
WASHINGTON,DC (RUSHPRNEWS) 09/08/2008–The U.S. Food and Drug Administration announced today that it has posted on its Web site its first quarterly report that lists certain drugs that are being evaluated for potential safety issues. The drugs have been identified based on a review of reports in FDA’s Adverse Event Reporting System (AERS).
Read more
FDA Clears Test to Help Doctors Manage Heart Transplant Patients
September 2, 2008
WASHINGTON,(RUSHPRNEWS) 02.09/2008–The U.S. Food and Drug Administration today announced it has cleared for marketing a non-invasive test that uses molecular expression techniques to assist doctors in managing heart transplant patients post-surgery for potential organ rejection.



